RN7SL140P

Across TCGA pan-cancer cohorts, RN7SL140P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RN7SL140P data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher RN7SL140P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL140P expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

CHOL, KICH, and KIRP are the cancer types where RN7SL140P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	DFS	Tertile	All	0.045	0.486	.009	45	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	36	view →
KIRP	DFS	Tertile	III,IV	0.229	0.709	.003	36	view →
SKCM	DFS	Tertile	III,IV	0.037	0.613	<.001	18	view →
PCPG	DFS	Tertile	All	0.063	0.924	<.001	18	view →
LUAD	OS	Tertile	All	0.146	0.406	.012	15	view →
TGCT	DFS	Tertile	All	0.132	0.677	.041	12	view →
STAD	DFS	Tertile	IV	0.621	0.210	.039	9	view →
GBM	OS	Tertile	All	0.089	0.415	.037	9	view →
LGG	DFS	Tertile	All	0.231	0.756	.009	9	view →
BRCA	OS	Tertile	III,IV	0.621	0.908	.020	6	view →
BLCA	OS	Tertile	III,IV	0.460	0.592	.047	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RN7SL140P–CHOL (DFS)

Open the CHOL breakdown →